Fujifilm announced an additional investment of $1.2 billion in its large-scale cell culture contract development and manufacturing organization (CDMO) business to further expand the planned Fujifilm Diosynth Biotechnologies facility in Holly Springs, North Carolina, bringing the total investment in the facility to over $3.2 billion. Plans for the new site were unveiled in September last year.
Air Liquide is to expand its capacities in biomethane, also known as renewable natural gas (RNG) in the US, with the construction of two new production units. These units, located in Center Township, Pennsylvania, and Holland Township, Michigan, will treat waste sourced from dairy farms.
Novoloop, a plastic circular economy technology company, recently announced the successful startup of its pilot plant in India in collaboration with Aether Industries, a publicly listed specialty chemicals manufacturer.
Specialty chemicals company Orion, a producer of carbon black, broke ground on a battery materials plant in Texas, US. According to Orion, the facility will be the only one in the US producing acetylene-based conductive additives for lithium-ion batteries and other applications for the growing electrification.
Roquette, a French multinational supplier of pharmaceutical and nutraceutical excipients, announced an investment by its venture capital arm Roquette Ventures in Danish start-up Biograil.
TotalEnergies and China Petroleum and Chemical Corporation (Sinopec) have agreed to develop a production unit for sustainable aviation fuel (SAF) at a Sinopec's refinery in China.
Upperton Pharma Solutions was joined by Sarah Gilbert, Professor and co-creator of the Oxford/AstraZeneca COVID-19 vaccine for the official opening of its new development and GMP manufacturing facility in Nottingham, UK.
Swiss specialty chemicals producer Archroma announced plans to expand its US operations in Martin, South Carolina.
Aragen, a CRDMO, has launched the first phase of its biologics manufacturing facility in Bangalore, India. The $30 million project, executed by its subsidiary Aragen Biologics Pvt Ltd, has completed its first small-scale manufacturing project for a US-based organization, producing a novel anticancer monoclonal antibody.
Syensqo has opened its application development labs (ADL) in Bollate, Italy. The project includes an expansion of 1,300 m2 in a new building and represents a €10 million investment over the past three years and underlines the Bollate research center’s pivotal role in developing new applications for high-tech industries, the company said.
Sandoz, a generic and biosimilar medicines manufacturer, recently opened a new production facility in Kundl, Austria, to serve more patients with affordable life-saving drugs produced entirely in Europe.
Dow announced its intent to build a world-scale carbonate solvents production facility for lithium-ion battery production on the US Gulf Coast. The plant will serve customers in the lithium-ion battery sector, in which carbonate solvents are used as a component in electrolytes.
In a move to triple its production of glass and polymer syringes for the US market by 2030, Germany’s Schott Pharma announced plans to build its first US facility to manufacture prefillable polymer syringes that meet the need for deep-cold storage and transportation of mRNA medications.
Greentech firm Afyren Neoxy, a subsidiary of Afyren, received a €3.4 million payment this week for achieving key milestones with its bio-based low-carbon products.
Interview with Edgardo Hernandez, President Manufacturing, Lilly
US CDMO Adare Pharma Solutions is to add a high-shear mixer granulator at its Pessano, Italy facility, to complement existing fluid bed capabilities. The new mixer can provide wet granulation using either aqueous or organic-based solutions.
Japan-based pharmaceutical company Kyowa Kirin plans to build a $200 million biologics manufacturing center in Sanford, North Carolina, creating 102 jobs. This will be the company’s first North American pharmaceutical manufacturing operation, expected to create 102 jobs.
South Korea-based contract development and manufacturing organization (CDMO) SK Bioscience has broken ground on an approximately 4,200 m2 expansion of its L House vaccine manufacturing facility in Andong, Gyeongsangbuk-do, South Korea, which will serve as the production base for pneumococcal conjugate vaccine candidate GBP410, jointly developed by SK Bioscience and Sanofi, who are co-investing in the expansion.
AstraZeneca, whose CEO Pascal Soriot has been critical of the UK business environment for the life sciences industry in the past, wants to invest a large sum at its homebase. On Mar. 6, Chancellor Jeremy Hunt announced that the pharma giant plans to invest £650 million in the UK.
AkzoNobel has completed a significant investment project at its production facility in Bac Ninh province, Vietnam, aimed at strengthening the company’s position in Asia and focusing on more sustainable manufacturing. The total investment amounts to €18.5 million.
Bristol Myers Squibb (BMS) wants to invest $400 million for the construction and design of a sterile drug product (SDP) facility at its Cruiserath campus in Dublin, Ireland, significantly expanding manufacturing and laboratory capacity at the site.
Dutch paints and coatings group AkzoNobel has been opened a new €26 million manufacturing plant Faisalabad, Pakistan – the company’s largest investment in the country to date.
Merck will open a new € 20 million distribution center in São Paulo, Brazil to better serve its Life Science customers in the region. The new space, which will be operational in late February, has an area of 13,000 square meters, which is twice as large as the former São Paulo location.
Sweden-based specialty chemicals company Perstorp has built and commissioned a new ISCC Plus-certified plant in western India to meet the growing market demand for Penta chemicals.
Brussels, Belgium-headquartered chemical company Solvay has completed the coal phase-out initiative at its US site in Green River, Wyoming.
The major capacity expansion was completed at AkzoNobel’s Powder Coatings site in Como, Italy. The expansion is aimed to secure supply to customers across Europe, the Middle East, and Africa (EMEA).
Air Liquide and Dow renewed their industrial gas supply agreement for Dow’s chemical production site in Stade, Germany. Under the long-term agreement, Air Liquide will supply industrial gases and invest almost €40 million in modernizing its facilities to increase operational efficiency and reduce CO₂ emissions.
In a move to launch its cell therapy platforms for critical cancer trials in the US, AstraZeneca is investing $300 million in a new facility in Rockville, Maryland. The site will initially focus on the production of T-cell therapies, with the possibility of supporting other disease areas in the future.
Brenntag announced the agreement to acquire a chemical logistics site of Chimica D’Agostino in Italy. The site is located in the industrial area of the city of Bari, well connected with Adriatic highway, and with easy access to harbours on the seaside.
Last week, AbbVie broke ground on a new Singapore manufacturing facility located in Singapore's Tuas Biomedical Park. The company will invest $223 million in the site which will add 24,000 l of biologics drug-substance capacity to AbbVie's global manufacturing network and support current products as well as emerging immunology and oncology compounds within its pipeline.
Hungary-headquartered specialty pharmaceutical company Gedeon Richter becomes a strategic investor of German biosimilars company Formycon via cash capital increase of 9.08% of Formycon’s share capital, which corresponds to €82.84 million.
Olon Group is building a state-of-the-art High Potency Active Pharmaceutical Ingredient (HPAPI) suite at its Olon USA site in Concord, Ohio. This expands the company's capabilities for handling HPAPI, with investments totaling around €40 million ($43 million) in recent years.
In a move to meet the rising demand from the photovoltaic industry, Solvay is expanding the is hydrogen peroxide capacity of its Shandong Huatai Interox Chemical site in China, a joint venture (JV) with Huatai Chemical.
Leading Indian carbon black player Birla Carbon announced to establish two new carbon black manufacturing sites in Naidupet, Andhra Pradesh, India, and Rayong, Thailand.
German drugmaker Boehringer Ingelheim is investing €120 million in an upgrade and expansion of its facility in Koropi, Greece, that will increase the company's capacity to produce existing and new medicines. Main disease areas, Boehringer said, include cardio-renal-metabolic (CRM) diseases, mental health, and pulmonary fibrosis.
